Literature DB >> 12126845

Proteomic patterns in serum and identification of ovarian cancer.

E P Diamandis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12126845     DOI： 10.1016/s0140-6736(02)09390-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Protein biomarkers of ovarian cancer: the forest and the trees.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Future Oncol       Date:  2012-01       Impact factor: 3.404

2.  Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.

Authors:  Madhumita Chatterjee; Saroj Mohapatra; Alexei Ionan; Gagandeep Bawa; Rouba Ali-Fehmi; Xiaoju Wang; James Nowak; Bin Ye; Fatimah A Nahhas; Karen Lu; Steven S Witkin; David Fishman; Adnan Munkarah; Robert Morris; Nancy K Levin; Natalie N Shirley; Gerard Tromp; Judith Abrams; Sorin Draghici; Michael A Tainsky
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

Review 3.  Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.

Authors:  M E de Noo; R A E M Tollenaar; A M Deelder; L H Bouwman
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

4.  Ovarian cancer classification based on dimensionality reduction for SELDI-TOF data.

Authors:  Kai-Lin Tang; Tong-Hua Li; Wen-Wei Xiong; Kai Chen
Journal:  BMC Bioinformatics       Date:  2010-02-27       Impact factor: 3.169

5.  Beyond CA125: the coming of age of ovarian cancer biomarkers. Are we there yet?

Authors:  Dimitra Sasaroli; George Coukos; Nathalie Scholler
Journal:  Biomark Med       Date:  2009-06-01       Impact factor: 2.851

6.  Proteomics and mass spectrometry for cancer biomarker discovery.

Authors:  Ming Lu; Kym F Faull; Julian P Whitelegge; Jianbo He; Dejun Shen; Romaine E Saxton; Helena R Chang
Journal:  Biomark Insights       Date:  2007-10-03

7.  Impact of freeze-thaw cycles and storage time on plasma samples used in mass spectrometry based biomarker discovery projects.

Authors:  Breeana L Mitchell; Yutaka Yasui; Christopher I Li; Annette L Fitzpatrick; Paul D Lampe
Journal:  Cancer Inform       Date:  2005

Review 8.  Applications of SELDI-MS technology in oncology.

Authors:  L C Whelan; K A R Power; D T McDowell; J Kennedy; W M Gallagher
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.